Drug intelligence / Profile preview

Covonia

Development stage
Unknown
Lead developer
Thornton & Ross
Modality
Drug Delivery Systems
Administration
Oral
01

Overview

Covonia is a UK over‑the‑counter brand of multi‑ingredient cough and cold medicines formulated to relieve chesty and dry coughs, sore throat, and associated cold and flu symptoms. Across the range, key actives include expectorants such as guaifenesin or traditional herbal expectorants (liquorice, squill, ipecacuanha) to loosen and aid clearance of bronchial mucus, demulcents such as glycerol and liquorice to soothe irritated pharyngeal mucosa, local antiseptics such as cetylpyridinium chloride to reduce microbial load in the throat, and the decongestant phenylephrine plus analgesic/antipyretic paracetamol in the All‑in‑One formulation to relieve nasal congestion, pain, and fever.[1][2][3][4][6][7][10][11] Formulations are supplied as oral liquids for short‑term symptomatic treatment of coughs, colds, influenza‑like illness, sore throat and related upper respiratory tract conditions in adults and children above age‑specific cut‑offs, and are produced and marketed in the UK by Thornton & Ross.

Brand names
Covonia

Beyond the preview

Go deeper on Covonia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Covonia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call